Study results positive for drug Amgen developing to treat osteoporosis
Thousand Oaks-based biotech giant Amgen and Brussels, Belgium-based UCB announced positive results in a Phase 3 trial of romosozumab, an antibody designed to treat osteoporosis. The drug works by inhibiting a protein which results in increased bone formation and decreased bone breakdown. However, the drug is not approved by any regulatory authority for use to Read More →
Santa Barbara Neighborhood Clinics get $325,000 to combat opioid abuse
The Santa Barbara Neighborhood Clinics received $325,000 of federal grant funding to combat opioid abuse. The U.S. Department of Health and Human Services awarded the funding through its Substance Abuse Service Expansion Awards program. The HHS has issued $94 million in grants to 271 health centers throughout the country to expand substance abuse services. Opioid Read More →
Startup Weekend Ventura County tests entrepreneurs’ mettle
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Tri-county nonprofits, health groups initiate dialogue
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Founder Hani Zeini resigns from Sientra board of directors
Sientra Chairman and CEO Jeffrey Nugent sent a letter to plastic surgeons on Feb. 19 announcing that the Goleta breast implant maker’s founder and former CEO Hani Zeini has resigned from Sientra’s board of directors. “We will be forever grateful to Hani for his vision and unwavering dedication to Sientra since its founding. Hani has been incredibly Read More →
Sientra implants back on market
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Port Hueneme’s Stellar Biotechnologies posts mixed earnings results
Stellar Biotechnologies saw revenues increase 130 percent during the first quarter of 2016 but the company still lost more money in 2016 than it did during the same quarter of 2015. The Port Hueneme-based company reported first quarter 2016 results after markets closed Feb. 8. Stellar makes a protein for immunotherapy treatments using a unique Read More →
